An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions.
Saved in:
| Title: | An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions. |
|---|---|
| Authors: | Joshi S; Joshi Clinic, Lilavati Hospital, Apollo Sugar Clinic and Bhatia Hospital, Mumbai, India., Gudi G; Drug Metabolism and Pharmacokinetics, Glenmark Pharmaceuticals Inc, Paramus, NJ, USA., Menon VCA; Drug Metabolism and Pharmacokinetics, Glenmark Pharmaceuticals Ltd, Mumbai, India., Tandon M; Clinical Development, Glenmark Pharmaceuticals Ltd, Mumbai, India., Joshi V; Clinical Research, Glenmark Pharmaceuticals Ltd, Mumbai, India., Suryawanshi S; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India., Barkate H; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India., Sawant N; Clinical Research, Glenmark Pharmaceuticals Ltd, Mumbai, India., Katare S; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India. sagar.katare@glenmarkpharma.com., Siddique W; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India. |
| Source: | Clinical pharmacokinetics [Clin Pharmacokinet] 2020 Mar; Vol. 59 (3), pp. 349-357. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31583610 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Joshi+S%22">Joshi S</searchLink>; Joshi Clinic, Lilavati Hospital, Apollo Sugar Clinic and Bhatia Hospital, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Gudi+G%22">Gudi G</searchLink>; Drug Metabolism and Pharmacokinetics, Glenmark Pharmaceuticals Inc, Paramus, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Menon+VCA%22">Menon VCA</searchLink>; Drug Metabolism and Pharmacokinetics, Glenmark Pharmaceuticals Ltd, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Tandon+M%22">Tandon M</searchLink>; Clinical Development, Glenmark Pharmaceuticals Ltd, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Joshi+V%22">Joshi V</searchLink>; Clinical Research, Glenmark Pharmaceuticals Ltd, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Suryawanshi+S%22">Suryawanshi S</searchLink>; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Barkate+H%22">Barkate H</searchLink>; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Sawant+N%22">Sawant N</searchLink>; Clinical Research, Glenmark Pharmaceuticals Ltd, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Katare+S%22">Katare S</searchLink>; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India. sagar.katare@glenmarkpharma.com.<br /><searchLink fieldCode="AU" term="%22Siddique+W%22">Siddique W</searchLink>; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227606849%22">Clinical pharmacokinetics</searchLink> [Clin Pharmacokinet] 2020 Mar; Vol. 59 (3), pp. 349-357. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+part+of+Springer+Science%2BBusiness+Media%22">Adis, part of Springer Science+Business Media </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>7606849 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1926 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203125963%22">03125963 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacokinet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31583610 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40262-019-00819-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 349 Titles: – TitleFull: An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Joshi S – PersonEntity: Name: NameFull: Gudi G – PersonEntity: Name: NameFull: Menon VCA – PersonEntity: Name: NameFull: Tandon M – PersonEntity: Name: NameFull: Joshi V – PersonEntity: Name: NameFull: Suryawanshi S – PersonEntity: Name: NameFull: Barkate H – PersonEntity: Name: NameFull: Sawant N – PersonEntity: Name: NameFull: Katare S – PersonEntity: Name: NameFull: Siddique W IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2020 Mar Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1179-1926 Numbering: – Type: volume Value: 59 – Type: issue Value: 3 Titles: – TitleFull: Clinical pharmacokinetics Type: main |
| ResultId | 1 |
